F S&P 500
5,288.50 +3.25 (+0.06%) F Dow Jones
39,164.00 +11.00 (+0.03%) F Nasdaq
18,696.00 -0.25 (-0.00%) E-mini Russell 2000 Index Futur
2,059.10 +5.40 (+0.26%) Petróleo
76.75 -0.12 (-0.16%) Oro
2,339.50 +2.30 (+0.10%)
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Shenhong Road, Building 20
7th Floor R&F Yuedu, Lane 988 Minhang District
Shanghai 201100
China
86 21 3328 3397
https://www.chengyipharma.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 738
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Chunjian Zhao | GM & Director | N/D | N/D | 1978 |
| Mr. Sun Zhan Lu | Chief Financial Officer | N/D | N/D | 1978 |
| Mr. Bing Jun Ren | VP & Director | N/D | N/D | 1965 |
| Mr. Shi Sheng Li | VP & Director | N/D | N/D | 1951 |
| Ms. Ze Hui Ke | Deputy GM, Secretary of the Board & Director | N/D | N/D | 1986 |
Descripción
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, capsules, tablets, pharmaceutical intermediates in China. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Shanghai, China.
Gestión corporativa
La calificación ISS Governance QuickScore de Zhejiang Cheng Yi Pharmaceutical Co., Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
